Table 2.
Method and timing of respondents’ VTE prophylaxis patterns
| Type of DVT/PE prophylaxis (multiple choice) | No. (%) |
|---|---|
| Sequential compression devices | 176 (91.2) |
| Low molecular weight heparin | 76 (39.4) |
| Unfractionated heparin q8 hours | 61 (31.6) |
| Unfractionated heparin q12 hours | 59 (30.6) |
| Time of administering DVT/PE prophylaxis | No. (%) |
| POD 0 | 103 (53.4) |
| POD ≥ 1 | 90 (46.6) |
| Hold administering of pharmacologic DVT/PE prophylaxis until laboratory values demonstrate no signs of coagulopathy or bleeding | (%) |
| Strongly agree and Agree | 34.2 |
| Neither agree nor disagree | 13.8 |
| Strongly disagree and Disagree | 52.0 |
VTE, venous thromboembolic; DVT, deep vein thrombosis; PE, pulmonary embolism, POD, post-operative day.